The Valley Desk

NCT05127434 · Interventional trial

A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

Overall registry status Completed

Phase 2 · Phase 3

Conditions Respiratory Syncytial Virus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov